Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Here’s Why

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) gapped up prior to trading on Wednesday . The stock had previously closed at $14.5595, but opened at $16.54. Ono Pharmaceutical shares last traded at $16.54, with a volume of 108 shares trading hands.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat, Ono Pharmaceutical currently has a consensus rating of “Strong Buy”.

Ono Pharmaceutical Trading Down 9.5%

The firm has a market cap of $7.02 billion, a PE ratio of 14.23 and a beta of 0.33. The firm has a fifty day simple moving average of $14.74 and a two-hundred day simple moving average of $14.79. The company has a current ratio of 3.28, a quick ratio of 2.56 and a debt-to-equity ratio of 0.08.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research?based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.